Charles River Laboratories traded at $222.72 this Tuesday July 5th, increasing $3.89 or 1.78 percent since the previous trading session. Looking back, over the last four weeks, Charles River Laboratories gained 9.10 percent. Over the last 12 months, its price fell by 40.99 percent. Looking ahead, we forecast Charles River Laboratories to be priced at 212.90 by the end of this quarter and at 196.06 in one year, according to Trading Economics global macro models projections and analysts expectations.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Agilent 120.56 1.35 1.13% -19.08%
AmerisourceBergen 140.71 -2.43 -1.70% 21.91%
Align Technology 254.11 6.77 2.74% -57.98%
Elevance Health Inc 476.94 -9.04 -1.86% 23.80%
Bio-Rad Laboratories 506.00 3.66 0.73% -24.18%
Bruker 64.99 1.45 2.28% -16.79%
Cardinal Health 52.25 -0.85 -1.60% -8.25%
Cigna 264.84 -3.19 -1.19% 12.58%
Charles River Laboratories 222.72 3.89 1.78% -40.99%
Catalent 105.99 -1.03 -0.96% -6.33%
CVS Health 92.53 -1.41 -1.50% 13.98%
Quest Diagnostics 133.58 -3.10 -2.27% 0.09%
Danaher 255.51 -2.54 -0.98% -8.33%
Galapagos 55.90 1.00 1.82% -1.43%
Hologic 70.19 0.05 0.07% 1.70%
Humana 472.92 -6.04 -1.26% 4.26%
Illumina 193.02 1.98 1.04% -59.35%
Incyte Corp 79.25 1.58 2.03% -4.91%
IQVIA Holdings Inc 215.31 0.26 0.12% -14.20%
Laboratory Of America 239.99 -0.95 -0.39% -13.85%
Lonza Group 539.20 9.60 1.81% -20.61%
McKesson 322.38 -7.15 -2.17% 70.27%
Allscripts Healthcare Solutions 15.12 -0.04 -0.26% -17.29%
Merck 169.70 1.85 1.10% 0.44%
Mettler Toledo International 1,175.47 13.62 1.17% -17.20%
Novartis 81.33 0.42 0.52% -4.28%
Pfizer 51.64 -0.67 -1.28% 31.43%
PerkinElmer 144.56 0.49 0.34% -7.34%
Thermo Fisher Scientific 545.07 -3.20 -0.58% 5.42%
UnitedHealth 505.24 -12.16 -2.35% 23.15%
United Therapeutics 237.15 -0.85 -0.36% 28.00%
Waters 339.66 2.77 0.82% -5.41%
Walgreens Boots Alliance 38.51 -0.05 -0.13% -19.27%
West Pharmaceutical Services 306.06 -1.68 -0.55% -17.05%
Intrexon 1.62 0.21 14.89% -74.12%
Dentsply International 36.10 -0.10 -0.28% -42.78%

Indexes Price Day Year
US400 2293 -2.92 -0.13% -14.44%

Charles River Laboratories
Charles River Laboratories International, Inc. is a full service, early-stage contract research company. The Company provides products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions in research and drug development. The Company operates through two segments: Discovery and Safety Assessment (DSA) and Manufacturing Solutions (Manufacturing). The DSA segment includes services required to take a drug through the early development process including discovery services, which are non-regulated services to assist clients with the identification, screening, and selection of a lead compound for drug development, and regulated and non-regulated (Good Laboratory Practice (GLP) and non-GLP) safety assessment services. The Manufacturing segment includes Microbial Solutions, Biologics Solutions, and Avian Vaccine Services.